½ÃÀ庸°í¼­
»óǰÄÚµå
1673922

¹ÙÀÌ¿ÀĨ ½ÃÀå : Á¦Ç° À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Biochips Market, By Product Type, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹ÙÀÌ¿ÀĨ ¼¼°è ½ÃÀåÀº 2025³â¿¡ 133¾ï 4,000¸¸ ´Þ·¯, 2032³â¿¡´Â 377¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 16.0%¸¦ º¸ÀÏ Àü¸ÁÀÔ´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 133¾ï 4,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 16.00% 2032³â °¡Ä¡ ¿¹Ãø 377¾ï 3,000¸¸ ´Þ·¯
±×¸². 2025³â Áö¿ªº° ¹ÙÀÌ¿ÀĨ ½ÃÀå Á¡À¯À²(%)
Biochips Market-IMG1

¼¼°è ¹ÙÀÌ¿ÀĨ ½ÃÀåÀº º´¿øÃ¼ ¹× À¯ÀüÀÚ¿¡¼­ ´Ü¹éÁú ¹× DNA ¿°±â¼­¿­¿¡ À̸£±â±îÁö »ý¹°ÇÐÀû ºÐÀÚÀÇ °ËÃâ ¹× ½Äº°¿¡ »ç¿ëµÇ´Â ±â¼ú·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀĨÀº ½Å¾à°³¹ß, Áúº´ Áø´Ü, ½Äǰ ¾ÈÀü µî¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Çõ½ÅÀûÀÎ ¹ÙÀÌ¿À¼¾¼­ ±â¼ú °³¹ßÀ» À§ÇÑ Á¤ºÎ ¹× ¹Î°£ ±â°üÀÇ ¿¬±¸°³¹ß ³ë·Â°ú ÀÚ±Ý Áö¿ø Áõ°¡°¡ ½ÃÀå °³Ã´ÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ºÐÀÚ»ý¹°ÇÐ ºÐ¾ßÀÇ ¹ßÀü°ú Á¤¹ÐÀÇ·áÀÇ ºÎ»óÀ¸·Î »ê¾÷°è Àü¹Ý¿¡ °ÉÃÄ ¹ÙÀÌ¿ÀĨÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀĨ ¼³°è ¹× Á¦Á¶ °øÁ¤ÀÇ °­È­´Â °¡±î¿î ¹Ì·¡¿¡ À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è ¹ÙÀÌ¿ÀĨ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¾Ï°ú °°Àº Áúº´ÀÇ À¯º´·ü Áõ°¡¿Í Á¶±â Áø´Ü¿¡ ´ëÇÑ °ü½ÉÀÔ´Ï´Ù. »ý¸í°øÇÐ ¹× »ý¸í°úÇÐ ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ È®´ëµµ »ýüºÐÀÚÀÇ »óÈ£ÀÛ¿ëÀ» Çö¹Ì°æ ¼öÁØ¿¡¼­ °¨ÁöÇÏ´Â ¹ÙÀÌ¿ÀĨ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ±×·¯³ª ¹ÙÀÌ¿ÀĨ °³¹ß¿¡´Â ³ôÀº ºñ¿ëÀÌ ¼Ò¿äµÇ¸ç, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀº Á¦Ç° ½ÂÀÎÀ» Áö¿¬½Ãų ¼ö ÀÖ½À´Ï´Ù. ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·Àº ¹ÙÀÌ¿ÀĨÀÇ º¸±ÞÀ» °¡·Î¸·°í ÀÖ½À´Ï´Ù. °³¹ßµµ»ó±¹¿¡´Â ¾ÆÁ÷ °³¹ßµÇÁö ¾ÊÀº ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î¾î·¹ÀÌ¿Í ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ±â¼úÀÇ ÃâÇöÀº ¹ÙÀÌ¿ÀĨÀÇ °ËÃâ ´É·ÂÀ» Çâ»ó½Ã۰í, ÇコÄɾ¼­ ȯ°æ ¸ð´ÏÅ͸µ ¹× ½Äǰ ¾ÈÀü °Ë»ç¿¡ À̸£±â±îÁö ÀÀ¿ë ºÐ¾ß¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù.

ÀÌ Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¹ÙÀÌ¿ÀĨ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Illumina, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc. µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿ÀĨ ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¹ÙÀÌ¿ÀĨ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ÁÖ¿ä ¹ßÀü
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±ÝÁ¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå, Á¦Ç° À¯Çüº°, 2020³â-2032³â(10¾ï ´Þ·¯)

  • DNA Ĩ
  • ¾Ï Áø´Ü ¹× Ä¡·á
  • À¯ÀüÀÚ ¹ßÇö
  • SNP Áö³ëŸÀÌÇÎ
  • À¯ÀüüÇÐ
  • Drug Discovery
  • ³ó¾÷ »ý¸í°øÇÐ
  • ±âŸ
  • ÇÁ·ÎÅ×ÀΠĨ
  • ´Ü¹éÁúüÇÐ
  • ¹ßÇö ÇÁ·ÎÆÄÀϸµ
  • Áø´Ü
  • HTS
  • ±âŸ
  • Lab-on-chip
  • IVD ¹× POC
  • ±âŸ
  • Á¶Á÷ ¾î·¹ÀÌ
  • ¼¿ ¾î·¹ÀÌ

Á¦6Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â(10¾ï ´Þ·¯)

  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¹× Á¦¾à ±â¾÷
  • Çмú¿¬±¸±â°ü
  • º´¿ø ¹× Áø´Ü¼¾ÅÍ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ¹ÙÀÌ¿ÀĨ ½ÃÀå, Áö¿ªº°, 2020³â-2032³â(10¾ï ´Þ·¯)

  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Fluidigm Corporation
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools
    • GE Healthcare
    • F. Hoffmann-La Roche AG
    • QIAGEN
    • Randox Laboratories Ltd
    • LI-COR, Inc.
    • Merck KGaA
    • Becton, Dickinson and Company
    • Arrayit Corporation
    • Nanostring Technologies, Inc.
    • GnuBio, Inc.

Á¦9Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

  • ±âȸ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map

Á¦10Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
LSH 25.04.14

Global Biochips Market is estimated to be valued at USD 13.34 Bn in 2025 and is expected to reach USD 37.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.0% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 13.34 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 16.00% 2032 Value Projection: USD 37.73 Bn
Figure. Biochips Market Share (%), By Region 2025
Biochips Market - IMG1

Global biochips market consists of technology used for detecting and identifying biological molecules from pathogens and genes to proteins and DNA sequences. Biochips are used in drug discovery, disease diagnosis, and food safety, among others. Increasing R&D efforts and funding from governments and private organizations for developing innovative biosensor technologies can drive the market growth. Advancements in fields of molecular biology and rise of precision medicine have accelerated the adoption of biochips across industries. Enhancements in biochip design and manufacturing processes can offer lucrative growth opportunities in the near future.

Market Dynamics:

Global biochips market growth is driven by rising prevalence of diseases like cancer and focus on early diagnosis. Growing investments in biotechnology and life science research also boosts demand for biochips to detect biomolecular interactions at microscopic levels. However, high costs associated with biochip development and strict regulatory norms can delay product approvals. Lack of skilled professionals can hamper its wider adoption. Untapped opportunities in developing nations present lucrative prospects. Emergence of microarray and microfluidic technology have improved detection capacities of biochips, thus, expanding application areas from healthcare to environmental monitoring and food safety testing.

Key features of the study:

This report provides in-depth analysis of the global biochips market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global biochips market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories Inc., PerkinElmer Inc., Fluidigm Corporation, and GE Healthcare

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biochips market

Detailed Segmentation-

  • By Product Type
    • DNA Chips
    • Cancer Diagnosis and Treatment
    • Gene Expression
    • SNP Genotyping
    • Genomics
    • Drug Discovery
    • Agricultural Biotechnology
    • Others
    • Protein Chips
    • Proteomics
    • Expression Profiling
    • Diagnostics
    • HTS
    • Others
    • Lab-on-chip
    • IVD & POC
    • Others
    • Tissue Arrays
    • Cell Arrays
  • By End User
    • Biotechnology and Pharmaceutical Companies
    • Academic & Research Institutes
    • Hospitals and Diagnostic Centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • PerkinElmer, Inc.
    • Fluidigm Corporation
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools
    • GE Healthcare
    • Hoffmann-La Roche AG
    • QIAGEN
    • Randox Laboratories Ltd
    • LI-COR, Inc.
    • Merck KGaA
    • Becton, Dickinson and Company
    • Arrayit Corporation
    • Nanostring Technologies, Inc.
    • GnuBio, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Biochips Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Biochips Market, By Product Type, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • DNA Chips
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cancer Diagnosis and Treatment
  • Gene Expression
  • SNP Genotyping
  • Genomics
  • Drug Discovery
  • Agricultural Biotechnology
  • Others
  • Protein Chips
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Proteomics
  • Expression Profiling
  • Diagnostics
  • HTS
  • Others
  • Lab-on-chip
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • IVD & POC
  • Others
  • Tissue Arrays
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cell Arrays
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Biochips Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Biotechnology and Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic & Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hospitals and Diagnostic Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Biochips Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Agilent Technologies, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PerkinElmer, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Fluidigm Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Illumina, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Thermo Fisher Scientific, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bio-Rad Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Standard BioTools
    • GE Healthcare
    • F. Hoffmann-La Roche AG
    • QIAGEN
    • Randox Laboratories Ltd
    • LI-COR, Inc.
    • Merck KGaA
    • Becton, Dickinson and Company
    • Arrayit Corporation
    • Nanostring Technologies, Inc.
    • GnuBio, Inc.

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦